High-density lipoprotein cholesteryl ester and protein catabolism in hypercholesterolemic rats induced by copper deficiency

Timothy P. Carr, K. Y. Lei

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

High-density lipoprotein (HDL) catabolism induced by copper deficiency was examined in vivo in hypercholesterolemic Sprague-Dawley rats. Doubly labeled HDL was used to trace the catabolic pathways of both cholesteryl ester and protein moieties of HDL particles. The catabolic rate of removal from the plasma, as well as uptake by various tissues, was determined for each HDL component. Copper-deficient rats exhibited a 30% increase in HDL cholesterol concentration, confirming hypercholesterolemia. In addition, plasma volume was enlarged 38% in deficient animals, resulting in a significantly increased intravascular pool of all HDL components of at least 60%. These data emphasize the importance of determining plasma volume and total pool size of pertinent plasma components in this hypercholesterolemic model. The absolute catabolic rate (ACR) of HDL protein removal from the plasma was 360 ± 22 and 278 ± 12 μg/h in copper-deficient and control rats, respectively. The ACR of HDL cholesteryl ester was 647 ± 37 μg/h in deficient animals and 321 ± 13 μg/h in controls, suggesting that the mechanisms of selective clearance of HDL cholesteryl ester (compared with protein) were increased threefold by copper deficiency. Virtually all of the increased removal of HDL cholesteryl ester in deficient rats occurred in the liver. Since previous studies indicate that increased hepatic cholesterol excretion may not occur in copper deficiency, the present results suggest that cholesterol delivered to the liver as HDL cholesteryl ester is possibly reassembled into new HDL particles at an increased rate in copper-deficient rats.

Original languageEnglish (US)
Pages (from-to)518-524
Number of pages7
JournalMetabolism
Volume39
Issue number5
DOIs
StatePublished - May 1990

Fingerprint

Cholesterol Esters
HDL Lipoproteins
Copper
Proteins
Plasma Volume
Cholesterol
Liver
Hypercholesterolemia
HDL Cholesterol
Sprague Dawley Rats
Blood Proteins

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

High-density lipoprotein cholesteryl ester and protein catabolism in hypercholesterolemic rats induced by copper deficiency. / Carr, Timothy P.; Lei, K. Y.

In: Metabolism, Vol. 39, No. 5, 05.1990, p. 518-524.

Research output: Contribution to journalArticle

@article{8834c0210d804e8b9fe02ff796383177,
title = "High-density lipoprotein cholesteryl ester and protein catabolism in hypercholesterolemic rats induced by copper deficiency",
abstract = "High-density lipoprotein (HDL) catabolism induced by copper deficiency was examined in vivo in hypercholesterolemic Sprague-Dawley rats. Doubly labeled HDL was used to trace the catabolic pathways of both cholesteryl ester and protein moieties of HDL particles. The catabolic rate of removal from the plasma, as well as uptake by various tissues, was determined for each HDL component. Copper-deficient rats exhibited a 30{\%} increase in HDL cholesterol concentration, confirming hypercholesterolemia. In addition, plasma volume was enlarged 38{\%} in deficient animals, resulting in a significantly increased intravascular pool of all HDL components of at least 60{\%}. These data emphasize the importance of determining plasma volume and total pool size of pertinent plasma components in this hypercholesterolemic model. The absolute catabolic rate (ACR) of HDL protein removal from the plasma was 360 ± 22 and 278 ± 12 μg/h in copper-deficient and control rats, respectively. The ACR of HDL cholesteryl ester was 647 ± 37 μg/h in deficient animals and 321 ± 13 μg/h in controls, suggesting that the mechanisms of selective clearance of HDL cholesteryl ester (compared with protein) were increased threefold by copper deficiency. Virtually all of the increased removal of HDL cholesteryl ester in deficient rats occurred in the liver. Since previous studies indicate that increased hepatic cholesterol excretion may not occur in copper deficiency, the present results suggest that cholesterol delivered to the liver as HDL cholesteryl ester is possibly reassembled into new HDL particles at an increased rate in copper-deficient rats.",
author = "Carr, {Timothy P.} and Lei, {K. Y.}",
year = "1990",
month = "5",
doi = "10.1016/0026-0495(90)90011-Z",
language = "English (US)",
volume = "39",
pages = "518--524",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - High-density lipoprotein cholesteryl ester and protein catabolism in hypercholesterolemic rats induced by copper deficiency

AU - Carr, Timothy P.

AU - Lei, K. Y.

PY - 1990/5

Y1 - 1990/5

N2 - High-density lipoprotein (HDL) catabolism induced by copper deficiency was examined in vivo in hypercholesterolemic Sprague-Dawley rats. Doubly labeled HDL was used to trace the catabolic pathways of both cholesteryl ester and protein moieties of HDL particles. The catabolic rate of removal from the plasma, as well as uptake by various tissues, was determined for each HDL component. Copper-deficient rats exhibited a 30% increase in HDL cholesterol concentration, confirming hypercholesterolemia. In addition, plasma volume was enlarged 38% in deficient animals, resulting in a significantly increased intravascular pool of all HDL components of at least 60%. These data emphasize the importance of determining plasma volume and total pool size of pertinent plasma components in this hypercholesterolemic model. The absolute catabolic rate (ACR) of HDL protein removal from the plasma was 360 ± 22 and 278 ± 12 μg/h in copper-deficient and control rats, respectively. The ACR of HDL cholesteryl ester was 647 ± 37 μg/h in deficient animals and 321 ± 13 μg/h in controls, suggesting that the mechanisms of selective clearance of HDL cholesteryl ester (compared with protein) were increased threefold by copper deficiency. Virtually all of the increased removal of HDL cholesteryl ester in deficient rats occurred in the liver. Since previous studies indicate that increased hepatic cholesterol excretion may not occur in copper deficiency, the present results suggest that cholesterol delivered to the liver as HDL cholesteryl ester is possibly reassembled into new HDL particles at an increased rate in copper-deficient rats.

AB - High-density lipoprotein (HDL) catabolism induced by copper deficiency was examined in vivo in hypercholesterolemic Sprague-Dawley rats. Doubly labeled HDL was used to trace the catabolic pathways of both cholesteryl ester and protein moieties of HDL particles. The catabolic rate of removal from the plasma, as well as uptake by various tissues, was determined for each HDL component. Copper-deficient rats exhibited a 30% increase in HDL cholesterol concentration, confirming hypercholesterolemia. In addition, plasma volume was enlarged 38% in deficient animals, resulting in a significantly increased intravascular pool of all HDL components of at least 60%. These data emphasize the importance of determining plasma volume and total pool size of pertinent plasma components in this hypercholesterolemic model. The absolute catabolic rate (ACR) of HDL protein removal from the plasma was 360 ± 22 and 278 ± 12 μg/h in copper-deficient and control rats, respectively. The ACR of HDL cholesteryl ester was 647 ± 37 μg/h in deficient animals and 321 ± 13 μg/h in controls, suggesting that the mechanisms of selective clearance of HDL cholesteryl ester (compared with protein) were increased threefold by copper deficiency. Virtually all of the increased removal of HDL cholesteryl ester in deficient rats occurred in the liver. Since previous studies indicate that increased hepatic cholesterol excretion may not occur in copper deficiency, the present results suggest that cholesterol delivered to the liver as HDL cholesteryl ester is possibly reassembled into new HDL particles at an increased rate in copper-deficient rats.

UR - http://www.scopus.com/inward/record.url?scp=0025215211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025215211&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(90)90011-Z

DO - 10.1016/0026-0495(90)90011-Z

M3 - Article

C2 - 2139917

AN - SCOPUS:0025215211

VL - 39

SP - 518

EP - 524

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 5

ER -